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Abstract
The transporter associated with antigen processing (TAP) is a key element of the major
histocompatibility complex (MHC) class I antigen processing and presentation pathway.
Nonfunctional TAP complexes impair the translocation of cytosol-derived proteolytic pep-
tides to the endoplasmic reticulum lumen. This drastic reduction in the available peptide rep-
ertoire leads to a significant decrease in MHC class I cell surface expression. Using mass
spectrometry, different studies have analyzed the cellular MHC class I ligandome from TAP-
deficient cells, but the analysis of the parental proteins, the source of these ligands, still
deserves an in-depth analysis. In the present report, several bioinformatics protocols were
applied to investigate the nature of parental proteins for the previously identified TAP-inde-
pendent MHC class I ligands. Antigen processing in TAP-deficient cells mainly focused on
small, abundant or highly integral transmembrane proteins of the cellular proteome. This
process involved abundant proteins of the central RNA metabolism. In addition, TAP-inde-
pendent ligands were preferentially cleaved from the N- and C-terminal ends with respect to
the central regions of the parental proteins. The abundance of glycine, proline and aromatic
residues in the C-terminal sequences from TAP-independently processed proteins allows
the accessibility and specificity required for the proteolytic activities that generates the TAP-
independent ligandome. This limited proteolytic activity towards a set of preferred proteins
in a TAP-negative environment would therefore suffice to promote the survival of TAP-defi-
cient individuals.
Introduction
The proteasome, as well as other cytosolic proteases, continuously degrades misfolded or pre-
maturely terminated proteins, also named defective ribosomal products (DRiPs), and mature
proteins with normal turnover kinetics. This proteolysis generates short peptides that are
transported into the endoplasmic reticulum (ER) by the transporter associated with antigen
processing (TAP) [1]. In the ER lumen, the multisubunit peptide-loading complex assembles
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nascent MHC class I heavy chain, β2-microglobulin and peptides to generate trimolecular sta-
ble MHC/peptide complexes that, after export to the cell surface, are recognized by cytolytic
CD8+ T lymphocytes (reviewed in [2]). This antigen presentation pathway is the key element
in the immune response against viruses and tumors.
Mutations in the TAP genes might generate nonfunctional TAP complexes that subse-
quently impair the transport of cytosolic peptides to the ER, as described both in mice [3] and
humans [4]. Animals and patients with this MHC class I immunodeficiency present a very lim-
ited functional CD8+ T cell population. Remarkably, these individuals have a limited predispo-
sition to suffer chronic respiratory bacterial, but not viral, infections or neoplasms and they
are asymptomatic for long periods. As cytotoxic CD8+ T cells are required to control and elim-
inate both malignant and virus-infected cells, their ability to recognize TAP-independent pep-
tide antigens seems to help protect against tumor and viral infections in
immunocompromised individuals.
Although TAP-independent viral epitopes were identified decades ago (reviewed in [5–7]),
very few studies have analyzed the cellular TAP-independent MHC class I peptidome [8–12].
In these articles, the properties of cellular TAP-independent ligands have been defined using
extensive analysis by mass spectrometry analyses. However, the nature of the parental proteins
of TAP-independent ligands has remained largely unaddressed. Thus, in the present report,
we applied several algorithms to perform an in-depth analysis of the features of the parental
proteins for TAP-independent MHC class I ligands identified by mass spectrometry.
Materials and methods
Data acquisition and management
Protein descriptors and peptide coordinates were obtained from the original references.
Sequences were collected using these descriptors from current versions of NCBI [13], IPI
(http://ftp.ebi.ac.uk/pub/databases/IPI/last_release/) and UniProt databases [14] Peptides
assigned to proteins that not were found in any of these databases (<0.5%), due to discontinu-
ation or deletion, were not considered in the analysis. Redundant sequences present in differ-
ent databases, were unified under one single descriptor using a BLAST all-against-all search of
the original data and applying the threshold of 100% for both identity and alignment length.
The correct positioning of the peptides in their respective protein sequences was verified in all
cases, using the original manuscripts.
Functional bioinformatics procedures
The isoelectric point and GRAVY index were calculated using the ProtParam tool of EXPASY
[15]. The GRAVY index was calculated using the Kyte and Doolitle hydrophobicity scale [16].
Transmembrane helices were predicted with TMHMM 2.0 [17]. Signal peptides were pre-
dicted with SignalP 4.1 by selecting eukaryotes as the organism group [18]. Gene Ontology
data were downloaded from GO web [19]. Human gene associations were downloaded from
http://www.ebi.ac.uk/GOA/human_release. RNA-Seq data from the spleen were downloaded
from RNA-Seq Atlas [20]. Proteins in the TAP dataset were compared to gene products in the
RNA-Seq Atlas using BLAST [21], and proteins showing >95% identity and >95% length
were considered identical. The human proteome was downloaded from the UniProt database
(http://www.uniprot.org/proteomes/UP000005640). Proteins were associated with a given
dataset (TAP+, TAP-C, TAP-NC or HLA-II) when they were strictly contained in the dataset
or the ratio to the observed to expected counts, considering the dataset size with respect to the
total, was greater than 2. Cleavage statistics and residue composition were assessed using in-
house Perl scripts.
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Statistics
The significance of countable variables was estimated using the Chi-square test by comparing
observed counts to those expected according to data from the control, TAP-sufficient cells.
Likewise, differences in distributions where assessed using two-tailed Student’s t-test by com-
paring the non-TAP+ datasets to the control TAP-sufficient dataset.
Results
Data description
Several datasets were examined to investigate the study of the TAP-independent antigen
processing pathways in TAP-deficient cells (Table 1). First, six datasets from four different
studies, including 1051 MHC class I ligands from 727 parental proteins, were collected
(Table 1). Individual studies contributed 42–543 peptides from 34–479 proteins. The TAP-
deficient antigen presentation was also split into classical (TAP-C) versus nonclassical
(TAP-NC) MHC, the latter was composed of the human HLA-E allele and its murine coun-
terpart H-2 Qa-1b. As controls, two studies analyzing HLA class I ligands from TAP-suffi-
cient (TAP+) cells (2125 peptides from 1557 proteins), including two of the alleles that were
also present in the TAP-independent set (HLA-A2 and HLA-B27), were selected (Table 1).
The initial data collection process was completed with six studies analyzing the HLA
class II (HLA-II) peptidome (2799 peptides from 1027 proteins). Variable sensitivities and
specificities should be expected due to the use of different techniques, the MHC alleles stud-
ied and the unavoidable variability of the laboratories involved. Nevertheless, the global
analysis of these studies must reflect the general rules that govern the TAP-independent
antigen presentation. However, the allele and study of origin were maintained throughout
the manuscript to monitor such biological and technical biases. Because one of the two
TAP-NC datasets was subjected to artificial length bias, we analyzed both datasets sepa-
rately as well.
Some proteins recurrently appear in several studies, providing different peptides that bind
to different alleles and are even represented in TAP-dependent, TAP-independent and HLA
class II antigen processing pathways. Thus, these proteins are efficiently processed in different
biochemical contexts. A relatively high overlap between TAP-independent and TAP-depen-
dent datasets at the protein level was found (26% for the TAP-independent dataset, Fig 1).
However, parental proteins from TAP-C and TAP-NC peptidomes only exhibited slight over-
lap (4%). Based on these data, the molecular rules governing antigen processing between
TAP-C and TAP-NC should differ.
Small and highly integral transmembrane proteins are a relevant source of
TAP-C ligands
Different features of the parental proteins from the four datasets were analyzed. The parental
proteins for TAP+, TAP-NC, and HLA-II ligands had similar lengths (Fig 2A). In contrast,
parental proteins for TAP-C ligands were significantly smaller than parental proteins for TAP+
(604 ± 667 vs 803 ± 877 average residues, P< 0.01; two-tailed Student’s t-test) and HLA class
II (692 ± 708 average residues, P< 0.01) ligands. However, no relevant differences were
observed in the pI and the hydrophobicity (Fig 2B and 2C).
In addition, the TAP+, TAP-C and TAP-NC datasets contained a comparable fraction of
transmembrane proteins (Fig 2D). Nevertheless, parental proteins for TAP-C ligands were
slightly enriched in membrane proteins with a highly integral character (>40% residues in
transmembrane helices, P< 0.05; Chi-square analysis) compared with the TAP+ dataset, with
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a percentage similar to parental proteins for HLA-II ligands (Fig 2D). The HLA-II dataset was
strongly enriched in membrane proteins, although the low percentage (<10%) of residues in
transmembrane helices of most of these proteins indicates that they are peripheral rather than
integral membrane proteins.
Table 1. Summary of datasets included in this study.
MHC TAP Number of peptides MHC restriction Number of proteins Reference
Class I, classical Independent 42 H-2Kd 34 [9]
Class I, classical Independent 112 HLA-A2 74 [10]
Class I, classical Independent 78 HLA-B27 40 [10]
Class I, classical Independent 196 HLA-B51 or -C1 122 [10]
Class I, non-classical Independent 80 H-2 Qa-1b 70 [11]
Class I, non-classical Independent 543 HLA-E 479 [12]
TOTAL 1051 819
MHC TAP Number of peptides MHC restriction Number of proteins Reference
Class I, classical Dependent 1545 HLA-A2 1140 [22]
Class I, classical Dependent 580 HLA-B27 487 [23]
TOTAL 2125 1557
MHC TAP Number of peptides MHC restriction Number of proteins Reference
Class II N/A 214 HLA class II 77 [24]
Class II N/A 612 HLA class II 321 [25]
Class II N/A 378 HLA class II 145 [26]
Class II N/A 448 HLA class II 143 [27]
Class II N/A 185 HLA class II 77 [28]
Class II N/A 962 HLA class II 264 [29]
TOTAL 2799 1027
https://doi.org/10.1371/journal.pone.0210583.t001
Fig 1. Overlap of parental proteins between the datasets included in this study. Venn diagram showing absolute
numbers of proteins shared between the different datasets analyzed: TAP-sufficient MHC class I (TAP+), TAP-
independent classical (TAP-C) and nonclassical (TAP-NC) MHC class I and MHC class II (HLA-II).
https://doi.org/10.1371/journal.pone.0210583.g001
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Protein abundance is a determining factor for TAP-C presentation
The cellular proteins encoded by mRNAs present at high concentrations are presumably abun-
dant. Previous studies have shown that abundant proteins are likely the main source of endog-
enous TAP+ ligands, although proteins synthesized from poorly transcribed mRNAs also
globally generate a significant fraction of these ligands [30–32]. Thus, considering the RNA
levels of a lymphoid tissue, i.e., the spleen, as an indicator of protein levels, we confirmed that
parental proteins for the TAP+ dataset were indeed more abundant than the average tran-
scripts from the whole human proteome. Moreover, the link between protein abundance and
MHC class I presentation was significantly stronger for the TAP-C dataset (Fig 3). In particu-
lar, proteins whose mRNAs are more abundant, measured as Reads Per Kilobase per Million
mapped reads (RPKMs) > 8 were represented at a 1.94-fold higher level in the TAP-C dataset
and its peptide contribution was 2.06-fold greater (P< 0.001; Chi-square test) than in the
TAP+ dataset.
Fig 2. Structural features of parental proteins for MHC class I and II ligands. Protein length (panel A), isoelectric point (panel B), hydrophobicity (GRAVY
index) distribution (panel C), and distribution of parental proteins according to the percentage of transmembrane residues (panel D) for the MHC peptidomes
included in each dataset: TAP+ (magenta bars), TAP-C (green bars), TAP-NC (orange bars), and HLA-II (black bars) ligands. In panel D, only membrane
proteins were considered.
https://doi.org/10.1371/journal.pone.0210583.g002
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Preferential processes and location of parental proteins for TAP-
independent MHC class I ligands
An assay comparing protein functions between the four datasets was conducted using gene
ontology enrichment. No biological processes were significantly associated with TAP+ ligands
consistent with the fact that the proteasome evenly samples the whole proteome. However, the
source of HLA-II ligands was highly enriched in genes involved in "immune and inflammatory
responses", and "extracellular" or "endocytosis" processes as previously described [33]
(Table 2). In addition, several central biological processes associated with mRNA production,
translation and expression were linked to the TAP-C ligandome, data that correlate with their
higher parental protein expression detected using the RPKM measurements (Fig 3). No bio-
logical processes were differentially associated with the generation of TAP-NC ligands. This
finding, together with the low overlap between the TAP-C and TAP-NC sets showed in Fig 1,
suggest that the source of these ligands seems to be different from TAP-C peptides (Table 2).
In addition, cellular components of the four datasets were analyzed (Table 3). No significant
cellular components were associated with the TAP+ ligandome, which was also consistent with
the ubiquitous protein degradation by the proteasome mentioned above. On the other hand,
HLA-II ligands were associated with proteins involved in the endocytic pathway (endoplasmic
reticulum, Golgi, vesicles, cell membrane, and extracellular matrix), as described in previous
studies [34]. The sources of TAP-C ligands were enriched in clusters associated with RNA pri-
mary transcription, ribosome or aggregation of proteins and RNAs that appear when the cell is
under stress, such as cytoplasmic stress granules (Table 3). Moreover, the cellular components
associated with the TAP-NC ligandome were enriched in DNA-related structures, such as the
kinetochore and chromatin. Altogether, these data support the existence of newly differenti-
ated MHC class I antigen processing pathways and compartmentalization to yield classical and
nonclassical TAP-independent ligands.
Fig 3. Distribution of MHC ligand-containing proteins relative to their mRNA expression levels. The expression of
the parental proteins for MHC class I and II ligands and the whole proteome were depicted as RPKM (Reads Per
Kilobase per Million mapped reads) of spleen mRNA levels determined using RNA-Seq. Similar to Figs 1 and 2, the
four MHC ligand datasets included in this study were separately analyzed. The code color is: whole proteome (white
bars), TAP+ (magenta bars), TAP-C (green bars), TAP-NC (orange bars), and HLA-II (black bars).
https://doi.org/10.1371/journal.pone.0210583.g003
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TAP-independent ligands were predominantly derived from the N- and, to
a greater extent, C-terminal regions of parental proteins
TAP+ ligands were evenly distributed over the sequence of respective parental proteins (Fig
4A), indicating that the antigen processing by proteasomes mainly occurs on fully denatural-
ized proteins, as was classically described. Reversely, when the position of the TAP-C ligan-
dome was mapped on the respective parental proteins whose lengths have been split into
deciles, a “smile-shaped” graph was obtained. Specifically, the two N-terminal and the C-ter-
minal deciles were overrepresented with respect the findings expected for random distribu-
tion, with an even more predominant contribution of the later category (Fig 4A). Although the
TAP-NC ligandome exhibited a similar random distribution to TAP+ ligands (Fig 4A), when
mouse and human HLA non classical alleles were separated, H-2 Qa-1b (but not HLA-E) also
showed a “smile-shaped” graph (Fig 4B). This finding likely indicates a different antigen pro-
cessing pathway for these HLA-E ligands compared with other TAP-independent ligands
bound to different classical human and nonclassical mouse MHC class I alleles, although an
artificial bias due to the exclusion of longer peptides in the original study cannot be excluded.
In addition, 21% of TAP-independent peptides were located exactly at the C-terminal position
of their respective proteins. In these cases, only one endoproteolytic cleavage event was needed
Table 2. Functional annotation clustering of biological process (GO term CC clustering) of parental proteins from different datasets.
GO term Description P-value Detected/Expected Dataset
0006955 immune response 4.2E-10 2.5 HLA-II
0006956 complement activation 1.6E-08 4.2 HLA-II
0002576 platelet degranulation 5.9E-08 2.6 HLA-II
0031295 T cell costimulation 7.7E-08 3.1 HLA-II
0010951 negative regulation of endopeptidase activity 1.0E-06 2.8 HLA-II
0006898 receptor-mediated endocytosis 1.2E-06 2.4 HLA-II
0008203 cholesterol metabolic process 1.3E-06 3.5 HLA-II
0030198 extracellular matrix organization 2.6E-06 2.0 HLA-II
0050852 T cell receptor signaling pathway 3.2E-06 2.7 HLA-II
0007186 G-protein coupled receptor signaling pathway 5.3E-06 2.4 HLA-II
0001895 retina homeostasis 7.0E-06 3.2 HLA-II
0050776 regulation of immune response 7.3E-06 2.2 HLA-II
0006954 inflammatory response 2.1E-05 2.2 HLA-II
0022617 extracellular matrix disassembly 3.5E-05 2.4 HLA-II
0006414 translational elongation 8.3E-09 3.7 TAP-C
0044267 cellular protein metabolic process 6.9E-08 2.4 TAP-C
0008380 RNA splicing 1.9E-06 2.9 TAP-C
0006412 translation 4.5E-06 2.7 TAP-C
0006415 translational termination 6.0E-06 3.3 TAP-C
0006413 translational initiation 9.5E-06 3.0 TAP-C
0006614 SRP-dependent targeting to membrane 1.1E-05 3.1 TAP-C
0019083 viral transcription 2.2E-05 3.0 TAP-C
0019058 viral life cycle 3.2E-05 2.8 TAP-C
0045892 negative regulation of transcription, DNA-templated 1.2E-04 2.9 TAP-C
0000184 nuclear-transcribed mRNA catabolic process 1.3E-04 2.8 TAP-C
0006397 mRNA processing 1.5E-04 3.0 TAP-C
0006457 protein folding 1.5E-04 3.0 TAP-C
0000398 mRNA splicing, via spliceosome 3.2E-04 2.5 TAP-C
https://doi.org/10.1371/journal.pone.0210583.t002
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to release these particular ligands. In contrast, exact N-terminal ligands generally were not
identified (less of 1% of peptides), indicating that most ligands required two different endopro-
teolytic cleavage events.
The C-terminal sequences of parental proteins for HLA-C ligands are
enriched in Gly, Pro and aromatic residues
The residue composition of the last 20 positions from the C-terminus of protein was analyzed
and compared with the TAP+ dataset to rationalize the abundance of TAP-C peptides in the
Table 3. Functional annotation clustering of cellular components (GO term CC clustering) of parental proteins from different datasets.
GO term Description P-value Detected/Expected Dataset
0005615 extracellular space 1.2E-28 2.5 HLA-II
0005576 extracellular region 6.2E-26 2.5 HLA-II
0072562 blood microparticle 8.1E-17 3.1 HLA-II
0009897 external side of plasma membrane 2.4E-12 3.1 HLA-II
0005578 proteinaceous extracellular matrix 2.0E-10 3.3 HLA-II
0005765 lysosomal membrane 2.1E-08 2.3 HLA-II
0042613 MHC class II protein complex 3.4E-08 3.8 HLA-II
0031012 extracellular matrix 1.0E-07 2.7 HLA-II
0032588 trans-Golgi network membrane 3.5E-07 3.2 HLA-II
0012507 ER to Golgi transport vesicle membrane 8.2E-07 2.4 HLA-II
0071556 integral component of lumenal side of ER 1.2E-06 2.4 HLA-II
0031093 platelet alpha granule lumen 6.7E-06 3.0 HLA-II
0042627 chylomicron 1.2E-05 4.1 HLA-II
0034361 very-low-density lipoprotein particle 2.4E-05 3.6 HLA-II
0030658 transport vesicle membrane 2.9E-05 2.9 HLA-II
0034362 low-density lipoprotein particle 6.4E-05 4.1 HLA-II
0034366 spherical high-density lipoprotein particle 6.4E-05 4.1 HLA-II
0071682 endocytic vesicle lumen 6.4E-05 4.1 HLA-II
0030666 endocytic vesicle membrane 7.6E-05 2.7 HLA-II
0030669 clathrin-coated endocytic vesicle membrane 9.8E-05 2.7 HLA-II
0030139 endocytic vesicle 1.4E-04 3.0 HLA-II
0043202 lysosomal lumen 1.5E-04 2.5 HLA-II
0034364 high-density lipoprotein particle 6.2E-04 3.4 HLA-II
0016324 apical plasma membrane 9.4E-04 2.1 HLA-II
0030529 ribonucleoprotein complex 1.3E-10 4.3 TAP-C
0005689 U12-type spliceosomal complex 3.8E-07 6.6 TAP-C
0022627 cytosolic small ribosomal subunit 1.8E-06 4.4 TAP-C
0005925 focal adhesion 5.6E-06 2.4 TAP-C
0010494 cytoplasmic stress granule 7.8E-06 5.5 TAP-C
0005903 brush border 1.5E-05 4.6 TAP-C
0071013 catalytic step 2 spliceosome 4.8E-05 3.4 TAP-C
0005681 spliceosomal complex 1.1E-04 3.7 TAP-C
0000776 kinetochore 6.4E-05 2.8 TAP-NC
0005832 chaperonin-containing T-complex 8.2E-05 4.2 TAP-NC
0000785 chromatin 3.4E-04 2.3 TAP-NC
0002199 zona pellucida receptor complex 5.4E-04 3.6 TAP-NC
0000922 spindle pole 6.3E-04 2.4 TAP-NC
https://doi.org/10.1371/journal.pone.0210583.t003
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C-terminal decile (Fig 4). No differences were observed with the exception of aromatic amino
acids, Gly and Pro residues, which were statistically significant different despite the inherent
noise (Fig 5). The two latter residues are common at the corner of turns in protein folds, which
were explicitly overrepresented in several of these positions in the TAP-C dataset (Fig 5A).
This effect was not observed in the extreme N-terminal, except for a Gly enrichment between
positions 12 and 34 (average of 10.2% vs 8.7% in the TAP+ control; P-value: 0.002; Student’s t
-test).
Cleavage specificity of peptidases involved in the generation of TAP-
independent ligands
Finally, the specificity of peptidases involved in generating ligands in TAP-defective cells was
addressed by determining the distribution of individual amino acid at the three flanking
Fig 4. Positions of MHC ligands in parental proteins. Relative positions relative to the protein N-terminus for TAP+
(magenta bars), TAP-C (green bars), TAP-NC (orange bars), and HLA-II (black bars) ligands (panel A). Panel B:
Murine (black bars) and human (white bars) MHC alleles in TAP-NC were analyzed separately.
https://doi.org/10.1371/journal.pone.0210583.g004
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residues (P3, P2, P1, P1´, P2´ and P3´) on both sides of the hydrolyzed bonds of MHC ligands.
Absolute residue counts at each position were normalized using the natural residue occurrence
in the selected proteins. Fig 6 shows the distribution of amino acids, clustered by biochemical
groups, found in the different flanking positions of scissile bonds.
The four datasets showed amino acids enrichment at several positions of flanking residues.
The specificity of peptidases involved in the generation of TAP-independent ligands was more
similar to peptidases that generate the TAP+ peptides than enzymes involved in generating
HLA-II antigens. However, as shown in Fig 6, differential enrichment of aromatic residues at
the P3 position of the hydrolyzed bonds in the TAP-C ligandome and aliphatic residues
enrichment at the P1 and P2 positions in the TAP-NC peptidome indicates that proteases with
different specificity are involved in classical MHC class I antigen presentation generating the
Fig 5. Relative residue occurrence in the C-terminus of parental proteins. Frequency of glycine and proline (panel
A) and aromatic (panel B) residues in the twenty C-terminal residues of parental proteins, where the first residue is the
last C-terminal residue in the sequence. The code color is in the same as described in Fig 4.
https://doi.org/10.1371/journal.pone.0210583.g005
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classical and nonclassical peptide pools. Additionally, mouse and human HLA non classical
alleles were separately analyzed, and differential enrichments of hydroxyl and amide (N/Q)
residues was observed at the P3, P2 and P2´ positions of parental murine proteins.
Discussion
In this study, we provide information on the features of parental proteins, the source of TAP-
independent ligands presented by alternative antigen processing pathways to the classical pro-
teasome, TAP-dependent pathway. These results may explain why TAP mutations do not
result in a lethal phenotype [3,4]. A systemic computational approach was used in the present
study.
Several thousand ligands bound to specific MHC class I alleles were identified in an immu-
noproteomic analysis of TAP-sufficient cells in the previous studies [22,23]. In contrast, in the
small number of similar studies examining TAP-deficient cells only tens [8,9] [11] or hundreds
[10,12] of TAP-independent MHC peptides have been described. This finding is consistent
with the very low expression of MHC class I molecules on the surface of TAP-deficient cells
compared with normal, TAP-sufficient cells. The main difference between TAP-dependent
and -independent MHC ligandomes analyzed using mass spectrometry in previous studies
was the increased peptide lengths and the absence of strict binding motifs in the latter. In the
later years, spliced peptides derived from a transpeptidation reaction mediates by proteasome
activity between fragments distant in the parental protein have been described [35,36].
Although these these peptides are also longer than the TAP-dependent ligands, their contribu-
tions to antigen processing in TAP-deficient cells are very limited [37]. These differences
between TAP-dependent and TAP-independent MHC ligandomes applied to all MHC class I
alleles studied. The exception was the study by Weinzierl et al. [8], in which, in contrast to
other TAP-independent peptidomes analyzed, the ligands were theoretically assigned to the
Fig 6. Analysis of N- and C-terminal cleavage specificity in MHC ligands. A diagram of residues involved in the
generation of naturally processed MHC ligands by peptidase cleavage is shown (panel A). Distribution of P1 to P3 and
P´1 to P´3 amino acid residues of the scissile bonds created by peptidase cleavage in the four datasets of (panel B)
murine (black bars) and human (white bars) MHC allele in TAP-NC were separately analyzed (panel C). Only residues
displaying 2-fold enriched with respect to the expected value and with p-values< 0.001 were considered.
https://doi.org/10.1371/journal.pone.0210583.g006
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respective HLA class I molecules using two in silico web tools: BIMAS (https://www-bimas.cit.
nih.gov/) and SYFPEITHI (http://www.syfpeithi.de/) that only predict 8, 9 or 10 mer high
affinity ligands. Thus, longer peptides or ligands with a low predicted HLA binding score (the
majority of TAP-independent ligands in other mass spectrometry analyses performed [9,10])
were not detected by these algorithms and thus, the conclusions might be biased towards a
rather limited nonrepresentative subset of the total TAP-independent HLA peptidome. There-
fore, this study was not included in the present report. On the other hand, the data reported by
Lampen et al. present an intermediate situation, since no bioinformatics strategy was used but
only 8–13 mer peptides were manually included in the analysis of the nonclassical HLA-E pep-
tidome [12]. Thus, in this mass spectrometry analysis, low affinity ligands were detected, but
the most striking TAP-independent ligands (whose length is even greater than 20 residues)
were excluded. This study was included in the current report, but independently analyzed to
detect possible sources of bias as these peptides were more hydrophobic. In addition, as the
same laboratory had previously analyzed the TAP-independent ligandome of murine ortholo-
gue (H-2 Qa-1b) of HLA-E with the same mass spectrometer and experimental procedures
without length restriction [11], the effect of length selection was studied. The analysis of fea-
tures of the proteins and peptides included in this report indicated that murine H-2 Qa-1b and
human HLA-E peptidomes differed, as TAP-independent H-2 Qa-1b ligands exhibited very
similar characteristics to TAP-C ligandomes from either murine or human TAP-deficient
cells. Therefore, dramatic differences do not exist between the antigen processing pathways for
classical or nonclassical TAP-independent ligands. Thus, the MHC peptidomes should be pref-
erentially analyzed without any methodological restriction in order to avoid reaching spurious
conclusions.
The prevalence of signal sequence-derived ligands was described in early mass spectrometry
analyses [38] [39] and in other studies, focused on the most abundant cellular peptides bound
to some HLA class I molecules [8] from TAP-deficient cells. This fact correlates with the bind-
ing specificity of the MHC class I molecules analyzed, HLA-A2 or -B51, which bind relatively
hydrophobic peptides. In contrast, for other MHC class I molecules with positively or nega-
tively charged residues as anchor motifs, the contribution of this pathway must be minor or
even residual because signal sequences do not tolerate theses residues. This finding is consis-
tent with the origin of the viral TAP-independent epitopes identified by analyzing T cell
immune responses. In a study of several MHC class I molecules, only 19% of TAP-indepen-
dent viral epitopes were derived from signal sequences, a value that was less than those derived
from other sources: luminal, transmembrane or even cytosolic proteins [40]. For example,
only 2 of 13 TAP-independent ligands naturally presented by six different HLA class I mole-
cules from vaccinia virus-infected TAP-deficient cells were derived from signal sequences
[41]. Moreover, these low percentages may be overestimated, since HLA-A2 is the most fre-
quently studied allele in antiviral immune responses.
Cellular proteins derived from highly abundant mRNA are much more common as a
source of the TAP-independent ligandome than TAP-dependent HLA class I ligands. In addi-
tion, biological processes associated with mRNA production, translation and expression were
also linked to the TAP-C ligandome. Both correlate with the poor performance of alternative
antigen processing pathways compared with the high efficiency of classical proteasome, -TAP-
dependent pathway. Thus, a reasonable hypothesis is that the protein abundance simply
increases the possibility of interaction with the different "nonprofessional" antigen-producing
proteases residing in the cellular compartments associated with TAP-independent antigen
processing pathways in a TAP-free environment. Although the peptide and mRNA data were
acquired from different sources, i.e., proteomic peptides from lymphoblastoid cell lines and
RNA-Seq data from the spleen, respectively, these are more biologically relevant in the natural
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environment of the later. Nevertheless, B cells are, by far, the predominant cellular type in the
mouse spleen. Therefore, a worst case explanation is our results are an underestimation of the
protein abundance as a key factor in TAP-deficient cells.
A strong tendency of TAP-C and H-2 Qa-1b to bind peptides located at the ends of the
parental protein was observed. Notably, 30% and 35% of the TAP-C ligandome were present
in the first two N- and the C-terminal sequence deciles, respectively. Similarly, 55% of H-2 Qa-
1b ligands were located in these regions. Unlike the proteasome, when the protein substrates
are unfolded by the 19S regulatory particle prior to their degradation, the peptidases that oper-
ate in the TAP-independent pathways must act on folded proteins. Only the surface of these
proteins would be exposed, even transiently, and susceptible to protease activity, which
reduces the diversity of potential ligands. These TAP-independent ligands were usually located
at the exact C-terminal position of their respective proteins. The underlying explanation for
this finding may be that peptides are released by a single cleavage event within the fully trans-
lated, likely folded protein which would favor the generation of ligands in a proteolysis-poor
context. In addition, we identified a relative over-occurrence of Gly and Pro residues in these
C-terminal regions. As Gly provides high flexibility to polypeptide chains, this amino acid is
frequently found in protein regions without secondary structures, such as loops or coils. Pro is
a structure-disrupting residue that is often found in loop regions. Altogether, this combination
might explain, in terms of accessibility to proteolytic targets, the preference of TAP-indepen-
dent antigen processing pathways for these C-terminal regions.
On the other hand, TAP-C or H-2 Qa-1b N-terminal peptides rarely include the first resi-
due itself and only Gly residue biases were observed in this terminal region. A plausible expla-
nation for the high N-terminal preference is the existence of nascent proteins that have not
reached the critical number of translated residues to trigger the folding process, and thus pro-
teases have a greater chance of targeting these sequences in this temporal window. In support
of this hypothesis, two of the three most significant enriched cellular component GO terms (P-
value < 10−4 compared to TAP+ data) for unique TAP-C proteins with peptides located in the
first 50 positions of the N-terminus were "extracellular exosome" and "membrane". These pro-
teins are initially cotranslationally inserted to the ER and thus, cleavages of their nascent
unfolded DRiPs would generate TAP-independent ligands for MHC binding.
A relative abundance of aromatic or aliphatic residues in different flanking positions of scis-
sile bonds and, for the Phe/Trp/Tyr amino acids, in the neighborhood of C-terminal regions
of parental proteins, was observed in regions that are preferential source of TAP-independent
ligands. Based in this finding, endoproteolytic proteases with specificity for these amino acids
are likely relevant in the antigen processing pathway in TAP-deficient cells. Among these
enzymes, cathepsins (MEROPS database: http://merops.sanger.ac.uk [42]), which were previ-
ously shown to involved in HLA class II antigen processing [43], show aromatic or aliphatic
cleavage specificities and would be relevant candidates for generation of the TAP-independent
ligands with adequate flanking regions.
Fundamental cellular processes, such as peptide presentation, rely on the robustness of pro-
teins networks and therefore they must be explored with the lens of systems biology. Thus,
antigen processing and presentation tolerates the absence of TAP by recruiting nonspecialized
proteases that act as a safety net when the involvement of the proteasome is limited. These sec-
ondary alternative pathways contribute residually to total antigen processing in TAP-sufficient
cells as assessed using TAP knockout-cell lines. Te safety range for peptide presentation is sub-
stantially reduced but still significantly active in these cells. This observation represents the
sum of marginal advantages that altogether counterbalance the lack of a dedicated proteolytic
machinery such as the proteasome. This collective alternative appears to be sufficient to sustain
the immunological clearance of most infections in TAP-deficient individuals.
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In summary, the global picture emerging from the current report suggests that the TAP-
independent antigen processing pathways are preferentially focused on small, abundant pro-
teins with numerous Gly, Pro and aromatic residues in their C-termini, favoring peptide gen-
eration through a single cleavage event. Both the still-unfolded N-terminal and unfolded C-
terminal sequences of parental proteins allow the protease to access and specifically perform
the proteolytic cleavages that mainly generate the TAP-independent peptidome.
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